Understanding of the role of insulin in the brain has gradually expanded, from initial conceptions of the brain as insulin-insensitive through identification of a role in regulation of feeding, to recent demonstration of insulin as a key component of hippocampal memory processes. Conversely, systemic insulin resistance such as that seen in type 2 diabetes is associated with a range of cognitive and neural deficits. Here we review the evidence for insulin as a cognitive and neural modulator, including potential effector mechanisms, and examine the impact that type 2 diabetes has on these mechanisms in order to identify likely bases for the cognitive impairments seen in type 2 diabetic patients.
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Introduction
For perhaps the past decade, it has been de rigeur to begin papers related to insulin and the brain with a note to the effect that 'contrary to previous dogma, insulin does indeed have effects on the brain.' This review will suggest that we have now moved beyond that point, such that a model of blood-borne insulin affecting the hypothalamus with regard to e.g. food intake and metabolic regulation is now itself dogma, but may need to be challenged or supplemented in (at least) two regards: the range of processes modulated by insulin and the location of insulin production. Specifically, we will suggest that cognitive deficits observed as a consequence of type 2 diabetes (T2DM) are likely due in large part to impaired central insulin modulation of cognitive and metabolic processes in the hippocampus and beyond, and that insulin signaling is a critical component of, for example, memory processing. The question of whether, and (if so) to what extent, insulin is produced centrally is a complex one, and we review the history of this area briefly in Section 5, together with analysis of findings thus far; excellent recent reviews from Kyriaki Gerozissis (Gerozissis, 2008 (Gerozissis, , 2010a (Gerozissis, , 2010b conclude (in contrast to conclusions drawn just a couple of years earlier; e.g. Banks, 2006 ) that the evidence for significant synthesis of insulin within the adult mammalian brain is now convincing to the point of being overwhelming. We agree with that conclusion, which is consistent with the findings reviewed here and supports the importance of consideration of brain insulin signaling beyond regulation of metabolism.
The focus of this review is on type 2, rather than type 1 (T1), diabetes. Although important recent papers consider potential mechanisms in common between T1 and T2 diabetes (e.g. Reagan, 2011; Stranahan et al., 2008) , and the two conditions share some common features (hyperglycemia, if untreated, being the most common and defining characteristic), there are many important differences, reflected in quite distinct cognitive and physiological profiles (Craft, 2009; Reagan, 2011; Wrighten, Piroli, Grillo, & Reagan, 2009 ); increased understanding of insulin's role within the brain supports the separation of the two conditions, and the effects of hyperglycemia per se are clearly distinct from those linked to insulin resistance (Gispen & Biessels, 2000a) . Perhaps most importantly in the present context, the peripheral lack of insulin seen in T1DM may not be reflected in lowered brain insulin ((Stranahan, Arumugam, et al., 2008) ; as might be expected if the brain is a source of insulin not reliant on pancreatic synthesis) and experimental induction of T1DM does not produce cognitive effects until several months after peripheral insulin production is impaired (Biessels et al., 1996; Kamal, Biessels, Duis, & Gispen, 2000) , suggesting that other factors (such as vascular effects, reduced brain glucose supply, altered glucocorticoid levels or many other possible effector mechanisms) may underlie cognitive changes in T1DM while brain insulin signaling may be at least relatively spared. Finally, the impact of T1DM on cognitive function in humans, as opposed to animal models, is small or absent in several studies (Group, 1991 (Group, , 1993 Jacobson et al., 2007; Kodl & Seaquist, 2008; Wrighten et al., 2009) ; even where present, the decline seen in T1DM is much slower than the effects of T2DM (Brands et al., 2007) , and may be due to nonspecific vascular and/or neurodegenerative effects, further arguing for separate evaluation of the two
